$189.25
0.20% today
Nasdaq, Feb 28, 04:49 pm CET
ISIN
IE0005711209
Symbol
ICLR
Sector
Industry

ICON Plc Stock price

$189.63
-12.63 6.24% 1M
-136.38 41.83% 6M
-20.08 9.58% YTD
-132.83 41.19% 1Y
-48.38 20.33% 3Y
+32.95 21.03% 5Y
+120.62 174.79% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-6.57 3.35%
ISIN
IE0005711209
Symbol
ICLR
Sector
Industry

Key metrics

Market capitalization $15.31b
Enterprise Value $18.38b
P/E (TTM) P/E ratio 19.88
EV/FCF (TTM) EV/FCF 16.66
EV/Sales (TTM) EV/Sales 2.22
P/S ratio (TTM) P/S ratio 1.85
P/B ratio (TTM) P/B ratio 1.61
Revenue growth (TTM) Revenue growth 1.99%
Revenue (TTM) Revenue $8.28b
EBIT (operating result TTM) EBIT $1.22b
Free Cash Flow (TTM) Free Cash Flow $1.10b
Cash position $538.79m
EPS (TTM) EPS $9.54
P/E forward 16.84
P/S forward 1.83
EV/Sales forward 2.20
Short interest 1.70%
Show more

Is ICON Plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

ICON Plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a ICON Plc forecast:

17x Buy
85%
3x Hold
15%

Analyst Opinions

20 Analysts have issued a ICON Plc forecast:

Buy
85%
Hold
15%

Financial data from ICON Plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
8,282 8,282
2% 2%
100%
- Direct Costs 6,334 6,334
0% 0%
76%
1,948 1,948
7% 7%
24%
- Selling and Administrative Expenses 140 140
0% 0%
2%
- Research and Development Expense - -
-
-
1,807 1,807
8% 8%
22%
- Depreciation and Amortization 588 588
6% 6%
7%
EBIT (Operating Income) EBIT 1,220 1,220
17% 17%
15%
Net Profit 791 791
29% 29%
10%

In millions USD.

Don't miss a Thing! We will send you all news about ICON Plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ICON Plc Stock News

Neutral
PRNewsWire
about 23 hours ago
LOS ANGELES , Feb. 27, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against ICON plc ("ICON" or the "Company") (NASDAQ: ICLR). IF YOU SUFFERED A LOSS ON YOUR ICON INVESTMENTS, CLICK HERE BEFORE APRIL 11, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is...
Neutral
PRNewsWire
one day ago
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR). Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Neutral
PRNewsWire
one day ago
SAN DIEGO , Feb. 26, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of ICON PLC (NASDAQ: ICLR) ordinary shares between July 27, 2023 and October 23, 2024.  ICON is a clinical research organization (CRO).
More ICON Plc News

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Head office Ireland
CEO Stephen Cutler
Employees 41,900
Founded 1989
Website www.iconplc.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today